Sugi Predict

Sugi Predict / Compounds / SCHEMBL4898037

SCHEMBL4898037

SCHEMBL4898037

COC(=O)c1cc(S(=O)(=O)NCCc2ccc(Oc3ccc(F)cc3)cc2)cc(C)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.56
▸ POLB P06746 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SGMS1 Q86VZ5 2/20 0.45
▸ AKR1C3 P42330 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ TAAR1 Q96RJ0 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TBXA2R P21731 1/20 0.41
▸ TBXAS1 P24557 1/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904027 0.91 ALDH1A1 (0.53) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4908345 0.91 MAPT (0.46) ALDH1A1POLBSMN1; SMN2AKR1C3MAPT
SCHEMBL4904169 0.91 ALDH1A1 (0.46) ALDH1A1POLBSMN1; SMN2AKR1C3MAPT
SCHEMBL4903947 0.91 MEN1 (0.51) ALDH1A1POLBSMN1; SMN2SGMS1AKR1C3
SCHEMBL4906257 0.91 ALDH1A1 (0.54) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4906445 0.90 PKM (0.47) ALDH1A1POLBSMN1; SMN2AKR1C3MAPT
SCHEMBL4904277 0.90 MAPT (0.50) ALDH1A1SMN1; SMN2SGMS1AKR1C3MAPT
SCHEMBL4903989 0.90 ALDH1A1 (0.61) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4906408 0.89 ALDH1A1 (0.44) ALDH1A1POLBSMN1; SMN2AKR1C3MAPT
SCHEMBL4906174 0.89 HTT (0.52) ALDH1A1POLBTDP1SMN1; SMN2AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 — — US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885POLB 1488/4885CYP1A2 1923/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885POLB 1807/4885CYP1A2 2009/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885POLB 1807/4885CYP1A2 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.